1242 Mouse model of CAR-related ICANS development after treatment with human CD19 CAR-T cells
Main Authors: | Alice Bergamini, Barbara Camisa, Chiara Bonini, Monica Casucci, Laura Falcone, Elena Tiziano, Rita El Khoury, Rossana Norata, Francesca Sanvito, Tamara Canu, Patrizia D’Adamo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
306 N-glycosylation inhibition hinders immunosuppressive tumor microenvironment cells improving CAR T cell efficacy
by: Alice Bergamini, et al.
Published: (2023-11-01) -
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses
by: Alice Bergamini, et al.
Published: (2023-01-01) -
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome
by: Silvia Arcangeli, et al.
Published: (2022-06-01) -
Next-Generation Manufacturing Protocols Enriching TSCM CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients
by: Silvia Arcangeli, et al.
Published: (2020-06-01) -
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene
by: Monica Casucci, et al.
Published: (2018-03-01)